EPCAM and cancer: In patients with ovarian cancer, Taylor and colleagues identified a tumor-specific signature of eight miRNAs in EpCAM+ exosomes detectable in patient's plasma, as a disease-specific signature that discriminate cancer from benign ovarian disease [25].